ALLOX - About the company
ALLOX is a funded company based in Barcelona (Spain), founded in 2023 by Julia Domingo, Ben Lehner, Pablo Baeza Centurion and Andre Faure. It operates as an AI-powered drug discovery platform to treat human diseases. The company has 140 active competitors, including 43 funded and 13 that have exited. Its top competitors include companies like Seer, Biognosys and Peptris.
Company Details
AI-powered drug discovery platform to treat human diseases. The company harnesses the power of genetics and AI to design new drugs targeting allosteric sites within oncology and other diseases.
- Website
- www.allox.bio/
- Social
- Email ID
- *****@allox.bio
Key Metrics
Founded Year
2023
Location
Barcelona, Spain
Stage
Funding Raised
Investors
Ranked
47th among 140 active competitors
Employee Count
25 as on Sep 30, 2026
Sign up to download ALLOX's company profile
ALLOX's funding and investors
ALLOX is a funded company. ALLOX has 1 institutional investor.
View details of ALLOX's funding rounds and investors
ALLOX's founders and board of directors
Founder? Claim ProfileHere are the details of ALLOX's key team members:
- Julia Domingo: Co-Founder of ALLOX. Contact Info: 1 email address
- Ben Lehner: Co-Founder of ALLOX. Contact Info: 1 email address
- Pablo Baeza Centurion: Co-Founder of ALLOX. Contact Info: 1 email address
- Andre Faure: Co-Founder of ALLOX. Contact Info: 1 email address
View details of ALLOX's Founder profiles and Board Members
ALLOX's employee count trend
ALLOX has 25 employees as of Sep 26. Here is ALLOX's employee count trend over the years:
Uncover ALLOX's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ALLOX's Competitors and alternates
Top competitors of ALLOX include Seer, Biognosys and Peptris. Here is the list of Top 10 competitors of ALLOX, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Seer 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | 72/100 | |
2nd | Biognosys 2008, Schlieren (Switzerland), Acquired | Provider of proteomics service | $9.13M | 63/100 | |
3rd | Provider of AI-based proteomic data analysis software for drug discovery | $9.17M | 60/100 | ||
4th | Talus 2020, Seattle (United States), Seed | Provider of drug discovery platform for gene regulators | $19.8M | 60/100 | |
5th | _1558516543928.png?devicePixelRatio=2&height=30&width=30){kind=logo} Unnatural Products 2016, Santa Cruz (United States), Series B | Developer of computational biology techniques platform to engineer peptides for undruggable targets | $83M | 57/100 | |
6th |  BridGene Biosciences 2018, Sunnyvale (United States), Series B | Developer of small-molecule drugs for the treatment of cancer | $78.5M | 57/100 | |
7th |  Atavistik 2021, Cambridge (United States), Series B | Developer of allosteric therapeutics for precision oncology and rare diseases | $260M | 55/100 | |
8th | Avenue Biosciences 2023, Palo Alto (United States), Seed | Biotechnology company that employs protein engineering solutions | $15.6M | 54/100 | |
9th |  Grove Biopharma 2020, Chicago (United States), Series A | Developer of AI-based drug modality platform for protein-based drugs | $34M | 54/100 | |
10th | ProteinSimple 2004, San Jose (United States), Acquired | Provider tools to help researchers with protein analysis | $94.3M | 54/100 | |
47th | AI-powered drug discovery platform to treat human diseases | - | 36/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ALLOX's competitors? Click here to see the top ones
ALLOX's Investments and acquisitions
ALLOX has made no investments or acquisitions yet.
Reports related to ALLOX
Here is the latest report on ALLOX's sector:
News related to ALLOX
Media has covered ALLOX for 1 event in last 1 year.
•
MOA Foodtech Raises $3.8M to Expand AI-Led, Waste-Fermented Egg Substitute & Yeast EnhancerGreen Queen•Sep 03, 2026•European Innovation Council, MOA foodtech, ALLOX, VEGA and 6 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about ALLOX
Explore our recently published companies
- Forge Constructors - Addison based, 2018 founded, Unfunded company
- DAB - United Kingdom based, Unfunded company
- Belfius Direct Verzekeringen Assurances - Belgium based, 1925 founded, Unfunded company
- STC Woodworking - West Milford based, Unfunded company
- Lis Harris Coaching - New York based, 2023 founded, Unfunded company
- AST Advanced Energy - United Arab Emirates based, 1991 founded, Unfunded company
